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Background: Purified protein derivative (PPD) has been used for more than half a century as an antigen for the
diagnosis of tuberculosis infection based on delayed type hypersensitivity. Although designated as “purified,” in
reality, the composition of PPD is highly complex and remains ill-defined. In this report, high resolution mass
spectrometry was applied to understand the complexity of its constituent components. A comparative proteomic
analysis of various PPD preparations and their functional characterization is likely to help in short-listing the relevant
antigens required to prepare a less complex and more potent reagent for diagnostic purposes.
Results: Proteomic analysis of Connaught Tuberculin 68 (PPD-CT68), a tuberculin preparation generated from
M. tuberculosis, was carried out in this study. PPD-CT68 is the protein component of a commercially available tuberculin
preparation, Tubersol, which is used for tuberculin skin testing. Using a high resolution LTQ-Orbitrap Velos mass
spectrometer, we identified 265 different proteins. The identified proteins were compared with those identified from PPD
M. bovis, PPD M. avium and PPD-S2 from previous mass spectrometry-based studies. In all, 142 proteins were found to be
shared between PPD-CT68 and PPD-S2 preparations. Out of the 354 proteins from M. tuberculosis–derived PPDs (i.e.
proteins in either PPD-CT68 or PPD-S2), 37 proteins were found to be shared with M. avium PPD and 80 were shared
with M. bovis PPD. Alignment of PPD-CT68 proteins with proteins encoded by 24 lung infecting bacteria revealed a
number of similar proteins (206 bacterial proteins shared epitopes with 47 PPD-CT68 proteins), which could potentially be
involved in causing cross-reactivity. The data have been deposited to the ProteomeXchange with identifier PXD000377.
Conclusions: Proteomic and bioinformatics analysis of different PPD preparations revealed commonly and differentially
represented proteins. This information could help in delineating the relevant antigens represented in various PPDs, which
could further lead to development of a lesser complex and better defined skin test antigen with a higher specificity and
sensitivity.
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Around 2 billion people in the world are infected with
M. tuberculosis. According to WHO world TB (tubercu-
losis) control report 2011, in 2010 alone, 9 million new
TB cases were reported and 1.45 million deaths occurred
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reproduction in any medium, provided the orinfectious killer disease after HIV. One in five of the 1.8
million AIDS related deaths are estimated to be associ-
ated with TB. Tuberculin skin test (TST) is the standard
test for the diagnosis of TB infection in the Western
world [1]. American Thoracic Society and Center for
Disease Control and Prevention recommend targeted
TST for deciding the treatment regimen among groups
associated with increased risk for progression of latent
tuberculosis infection (LTBI) to active TB [2]. Vaccin-
ation is an important preventive measure to control
community load of TB. An attenuated strain of M. bovis
known as Bacillus Calmette-Guerin (BCG) is universallyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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BCG is controversial as it does not protect against adult
forms of pulmonary tuberculosis [3,4]. Moreover, prior
exposure of individual to environmental mycobacteria
and organisms sharing antigenic epitopes results in re-
call of immune memory response to BCG administration
[3]. After almost 12 decades of research, we still do not
have a reliable diagnostic test for TB that can be used in
primary health care centers with definitive results.
In 1890, Robert Koch introduced boiled, crude extract
of tubercle bacilli in glycerin (referred as “old tubercu-
lin”) as a potential vaccine material against tuberculosis
infection [5-7]. Although Koch’s old tuberculin could
not be used as therapy because of its toxicity, impurity
and inadequate standardization; the concept of tubercu-
lin was instrumental in laying the foundation of the
modern TST [8]. TST, first introduced by Von Pirquet
in 1909 [6] has been in use as a standard method for
diagnosing TB infection almost over the last six decades
[8,9]. It is based on measuring the extent of induration
formed because of delayed type hypersensitivity reaction
elicited by mycobacterial antigens present in PPD.
In addition to its role in detecting mycobacterial infec-
tion, TST has also been used as a standard tool to esti-
mate the prevalence of LTBI [8]. The role of PPD in
serodiagnosis of TB, with sensitivity as high as 92%, was
reported in Warao and Creole populations [10]. Several
studies reported the use of PPD in serodiagnosis of tu-
berculosis infection with high sensitivity [11,12]. PPD
has also been used as a standard control in immuno-
logical assays [13]. It is reported that PPD improves the
sensitivity of interferon gamma release assay (IGRA).
IGRA uses early secretory antigenic target-6 (ESAT-6)
and culture filtrate antigen EsxB (CFP10) antigens
present in M. tuberculosis and M. bovis but not in BCG.
This can enable differentiation of TB-infected and BCG
vaccinated individuals [14,15]. However, Yassin et al.
reported that sensitivity of IGRA can be compromised
in children with severe malnutrition and HIV co-
infection. Concomitant use of TST, IGRA and interferon
gamma induced protein 10 (IP-10) in children staying in
contact with smear-positive adults has shown higher
number of children as positive [16]. In addition, IGRAs
suffer from limitations including higher cost, variable
sensitivity, poor reproducibility, limited interpretive cri-
teria and unknown prognostic value [17]. Despite its im-
portant applications, PPD is not considered as a reliable
material. This is due to high rates of false positive re-
sults, inability to distinguish between tuberculous and
non-tuberculous mycobacteria or individuals vaccinated
with BCG [18]. This can be attributed to immune re-
sponse elicited by antigens from BCG or environmental
bacteria sharing antigenic epitopes [19,20]. Earlier stud-
ies by Borsuk et al. identified molecular chaperone DnaK(DnaK), molecular chaperone GroEL (GroEL2), elongation
factor 2 (EF-Tu), cell surface lipoprotein Mpt83 (Mpt83)
and acyl carrier protein as abundant proteins common to
M. bovis and M. avium PPDs [21]. Moreover, discrepancy
of results has been observed between different PPD prepa-
rations [22,23]. Currently available PPD preparations used
on human subjects include PPD-S2 [6], PPD-RT23 [24],
PPD IC-65 [9,13] and PPD-CT68 [25].
Knowledge about the constituents of PPD could allow
the researchers to effectively work on PPD associated diag-
nostic complications. Earlier studies employed gel electro-
phoresis to identify constituents of PPD [26]. Kuwabara
and Tsumita in 1974 first attempted to identify and
characterize the components of PPD [27]. An analysis
which employed gel electrophoresis for characterization of
PPD antigens in whole cell lysate of M. bovis BCG resulted
in four protein bands corresponding to PPD [28]. Kitaura
et al. could distinctly identify only two ribosomal proteins
L7 and L12 in M. tuberculosis and M. bovis PPDs in gel
electrophoresis [29]. With the advent of high resolution
mass spectrometry, it is now possible to identify proteins
from complex peptide mixtures. Borsuk et al. identified
171 proteins in an LC-MS/MS analysis of Brazilian and
UK bovine and avium PPDs [19]. Cho et al. recently identi-
fied 240 proteins in PPD-S2 [26]. PPD-CT68, which is an-
other standard reagent used for TST, has not been
analyzed thus far. In the present report, we have analyzed
and described the proteome profile of PPD-CT68 using
high resolution mass spectrometry and compared it with
that of other PPDs derived from M. tuberculosis, M. avium
and M. Bovis. PPD-CT68 examined here was developed by
Landi in 1963 from “Johnston” strain of M. tuberculosis
var. hominis [30].
Results and discussion
Identification of proteins present in PPD-CT68 from
Mycobacterium tuberculosis
We carried out a proteomic profiling of PPD-CT68 pre-
pared from M. tuberculosis culture in a protein-free
medium using high resolution Fourier transform mass
spectrometry. Mass spectrometry-derived data was
searched using Sequest algorithm embedded in the
Proteome Discoverer software against a protein database
of M. tuberculosis from NCBI RefSeq. Search of 5,205 MS/
MS spectra resulted in 1,146 peptide-spectrum matches,
which corresponded to 695 unique peptides. The list of
peptides identified in this study is provided in Additional
file 1: Table S1. Representative MS/MS spectra are provided
in Figure 1. Based on these 695 unique peptides, we identi-
fied 265 proteins (Additional file 2: Table S2) of M. tubercu-
losis in PPD-CT68.
Cho and colleagues [26] recently reported the identifi-
cation of 240 proteins from PPD-S2, which is the stand-
ard for TST, as recommended by U.S. Food and Drug
m/z












































































































































































































Figure 1 MS/MS spectra of peptides from some of the M. tuberculosis PPD-CT68 proteins identified in this study (A) iron-regulated
peptidyl-prolyl cis-trans isomerase A (B) catalase-peroxidase peroxynitritase T KatG (C) molecular chaperone GroEL (D) polyketide synthase.
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http://www.clinicalproteomicsjournal.com/content/10/1/8Administration (FDA). Out of 240 proteins listed, 231 are
non-redundant. We compared proteomic results obtained
in our study with proteins identified from PPD-S2
(Figure 2A). Out of the 265 proteins identified from PPD-
CT68, 142 proteins were shared with PPD-S2, whereas,
123 and 89 proteins were exclusively identified from PPD-
CT68 and PPD-S2, respectively. Altogether, 354 proteins
of M. tuberculosis PPD have been identified.
For further understanding of protein profiles of various
PPD preparations, we compared the PPD derived from
M. tuberculosis (PPD-CT68 and PPD-S2) with PPDs of
M. bovis and M. avium [19] (Figure 2B). Out of 354 pro-
teins from M. tuberculosis PPDs, 37 proteins were found
common with M. avium PPD and 80 were common with
M. bovis PPD. We also found that 18 proteins were com-
mon in PPDs obtained from M. tuberculosis, M. bovis and
M. avium. When compared to PPDs from M. tuberculosis,
35 and 19 proteins were exclusively found in M. avium
and M. bovis PPDs respectively. It is also interesting to
note that 255 proteins were exclusively identified in PPDs
from M. tuberculosis.
Functional analysis of proteins common among all PPDs
We carried out functional classification of proteins identi-
fied in M. tuberculosis (PPD-CT68 and PPD-S2), which are
also present in M. avium and M. bovis. Most of the pro-
teins were implicated in causing infection and protecting
the pathogen against various metabolic stresses. Five of
eighteen proteins- secreted antigen 85A (FbpA), thiol
peroxidase (Tpx), bacterioferritin (BfrA), thioredoxin(TrxC) and lipoprotein LprG (LprG) - offer protection
against oxidative and nitrosative stress. On the other
hand, co-chaperonin GroES (GroES), DnaK, serine pro-
tease PepA (PepA), alanine and proline rich secreted
protein Apa (Apa) and hypothetical protein Mpt64 are
involved in causing infection. Detailed functional classi-
fication of each protein is given in the Table 1.
Bioinformatics analysis of PPD-CT68 proteins showing
homology to lung infecting bacteria
Raman et al. performed a comprehensive analysis on
M. tuberculosis genes homologous to 228 different patho-
genic bacteria [50]. We further analyzed 265 proteins rep-
resented in PPD-CT68 against the proteins encoded by 24
lung infecting bacteria selected from the list of 228 patho-
gens. Protein BLAST was performed to locate regions of
PPD-CT68 proteins sharing 10 or more identical amino
acid long regions with bacterial proteins. In all, 3,446 pep-
tides from 24 pathogens corresponding to 1,048 proteins
showed 10 or more amino acid identity with 117 proteins
from PPD-CT68 (Additional file 3: Table S3a and S3b).
Since, a peptide of 20 or more amino acid residues can be
a potential epitope, we further shortlisted the proteins
reflecting identity in a continuous stretch of 20 or more
amino acids (Additional file 3: Table S3c). Two hundred
and six out of 1,048 bacterial proteins showed identity
with 47 PPD-CT68 proteins. (Figure 3A). Functional ana-
lysis of 47 mycobacterial proteins sharing identical regions
revealed that 41% proteins are associated with intermedi-
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Figure 2 Overlap of proteins identified among PPD-CT68 and PPD-S2 (A) Proteins identified among M. tuberculosis PPD, M. avium PPD
and M. bovis PPD (B).
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http://www.clinicalproteomicsjournal.com/content/10/1/8pathways, 9% with virulence and detoxification, 4% with
cell wall and cell processes, 4% with lipid metabolism and
4% with regulatory proteins (Figure 3B).To further study the role of these 47 proteins in DTH and
serodiagnosis, we compared our data with immunoproteome
of M. tuberculosis reported by Velayudhan et al., which




1 AcpP Acyl carrier protein It shuttles the intermediates between the enzymes of type II fatty acid synthase system [31]
2 FbpA Secreted antigen 85-A It participates in cell wall biosynthesis, and interacts with the host
macrophage as fibronectin-binding protein. It is also involved in
establishment and maintenance of a persistent tuberculosis infection
[32,33]
3 GroES Co-chaperonin It is a dominant immunogenic protein [34]
4 DnaK Molecular chaperone It is highly antigenic and act as co-repressors for heat shock protein
transcriptional repressor (hspR)
[35]
5 Tpx Thiol peroxidase It protects M. tuberculosis against oxidative and nitrosative stress [36]
6 RpiL 50S ribosomal protein L7/L12 It is involved in interaction with translation factors [37]
7 BfrA Bacterioferritin It is an intracellular iron storage protein, which protects Mycobacterium
from oxidative stress mediated by excess iron
[38]
8 SahH S-adenosyl-L-homocysteine hydrolase It is a ubiquitous enzyme that plays a central role in methylation-based processes by
maintaining the intracellular balance between S-adenosylhomocysteine (SAH)
and S-adenosylmethionine
[39]
9 TrxC Thioredoxin It is involved in redox homeostasis and uses it to protect the pathoen against
the oxidative intermediates generated by the macrophages
[40]
10 FixB Electron transfer flavoprotein subunit
alpha
It is electron transfer flavoprotein subunit alpha, in some bacteria it functions
as nitrogen fixing agent but its function in M .tuberculosis is not clear
[41]
11 PepA Serine protease It is a serine protease associated with cell membrane, which stimulates peripheral blood
mononuclear cells from healthy PPD donors to proliferate and secrete gamma interferon
[42]
12 Wag31 Hypothetical protein It is a cell division initiation protein involved in regulation of genes
including virulence factors and antigens
[43]
13 Mpt64 Hypothetical protein It is an immunogenic protein which elicits delayed type hypersensitivity skin
response
[44]
14 Apa Alanine and proline rich secreted
protein
It is a cell surface glycoprotein which binds to host lectins and cheat
the innate immune system
[45]
15 LprG Lipoprotein LprG It plays a role in M. tuberculosis infection by inducing increased
suppression of the immune response due to elevated nitric oxide production
[46]
16 Rv1893 Hypothetical protein Function unknown [47]
17 Rv1855c Oxidoreductase Probable monooxygenase [48]
18 Gap Glyceraldehyde-3-phosphate
dehydrogenase
It has glyceraldehyde-3-phosphate dehydrogenase activity [49]
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sera collected from worldwide TB suspects [51]. Thirteen
proteins - DNA-directed RNA polymerase subunit beta;
DNA-directed RNA polymerase subunit alpha; GroEL;
30S ribosomal protein S1; fumarate hydratase; elong-
ation factor G; DnaK; aconitate hydratase; isocitrate
dehydrogenase; S-adenosyl-L-homocysteine hydrolase;
malate synthase G; D-3-phosphoglycerate dehydrogen-
ase; and enoyl-CoA hydratase - were recognized by
antibodies in serum. Out of these 13 proteins, only
seven (isocitrate dehydrogenase; malate synthase G;
succinyl-CoA synthetase subunit alpha; malate de-
hydrogenase; succinyl-CoA synthetase subunit beta;
aconitate hydratase; and type II citrate synthase) were
listed in immunoproteome and were identified in our
mass spectrometry analysis of PPD-CT68 [51]. These
proteins are associated with a host immune response
in cases with active tuberculosis.PPD proteins as candidate biomarkers
Available knowledge of the M. tuberculosis genes pro-
vides us the advantage to express and synthesize recom-
binant purified antigens, which gives us the opportunity
to test new biomarkers for TB infection. These antigens
can be used to detect the antibodies in the serum and
have a potential to improve diagnosis. Several studies
have explored the use of the recombinantly expressed
antigens and evaluated their immunodiagnostic poten-
tial. An updated systematic review on the diagnostic ac-
curacy of commercial serological tests for pulmonary
and extra pulmonary tuberculosis for relevant studies
was updated in May 2010 and WHO has performed a bi-
variate meta-analysis that jointly modeled both test sensi-
tivity and specificity (http://www.who.int/tb/laboratory/
policy_statements/en/index.html). It has been concluded
that the commercially available serological tests provide
inconsistent and imprecise findings and the sensitivity and
Proteins with >=20 amino acid identity
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Figure 3 Pie chart representing lung infecting bacterial proteins with <20 amino acid long peptides and ≥20 amino acid long peptides
identical to PPD-CT68 proteins (A). Functional classification of 47 PPD-CT68 proteins showing identity of 20 or more amino acids in 24 lung
infection associated bacterial proteins (B).
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http://www.clinicalproteomicsjournal.com/content/10/1/8specificity of the tests were highly variable. Our approach
presented in this study, has not only identified a large
number of proteins unique to M. tuberculosis, but in par-
allel provided the information on the coverage. The higher
the coverage, higher is the abundance of the protein in the
PPD sample analyzed. Our results are correlating with
earlier publications and many of the proteins identified in
the PPD of M. tuberculosis, have already been analyzed for
their potential as a diagnostic markers. Some of the hits
we have found are GroES [52,53], GroEL [54,55], protein
EsxB (EsxB) [56] heat shock protein HspX (HspX) [57],
hypothetical protein (TB15.3), hypothetical protien
(TB16.3) [58], 50S ribosomal protein L7/L12 (RplL)
[59], hypothetical protein (EsxA) [60], immunogenic
protein Mpt63 (Mpt63) [61], Mpt64 [62], ESAT-6 like
protein EsxJ (EsxJ), and ESAT-6 like protein EsxO
(EsxO) [63]. Based on these observations, many more
M. tuberculosis PPD can be analyzed and the abundant
antigens be evaluated for their potential as diagnostics
biomarkers.Clinical applications of the study
Based on our findings, out of 265 proteins identified in
PPD-CT68, 142 proteins were found common between
PPD-CT68 and PPD-S2. The common proteins can fur-
ther be evaluated for their potential as skin test antigens.
Proteins identified in our analysis, which are absent in
M. avium and M. bovis and do not show any significant
identity with proteins from lung infecting bacteria can be
shortlisted for developing various immunological assays to
identify M. tuberculosis, on the basis of their seroreactivity
and abundance. For example, Rv2346, Rv0379 and Rv1388
were found to be absent in PPD M. bovis and PPD
M. avium and possessed least identity with proteins from
lung infecting pathogens. As discussed earlier, one of the
major issues with the use of PPD as a skin test antigen is
false positive results for the individuals with BCG vaccin-
ation. Use of antigens absent in M. bovis may help over-
coming that. Global profiling of antigens in PPD may help
to identify M. tuberculosis-specific antigens, which are not
present in BCG. These antigens will be useful in
Prasad et al. Clinical Proteomics 2013, 10:8 Page 7 of 9
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can be prepared from M. tuberculosis, M. avium and M.
bovis, so if we can use antigen specific to every strain to
elicit the test response we can diagnose the species of
Mycobacteria with a simple skin test. Subset of antigens
that is mainly responsible for activating the immune re-
sponse can be used in adjunction with BCG or for booster
doses to enhance immune response. By knowing the anti-
gens involved in the test response, we can use minimal es-
sential amount of PPD for TST. Use of specific antigens in
TST will make it more specific and will reduce the false
positive results due to antigen cross reaction.
Conclusions
Despite the identification of almost a dozen antigens for
developing next generation PPD, it is challenging to
replace the classical PPD preparation. ESAT-6, Mpt64,
recombinant antigen (DPPD), CFP10, recombinant
truncated 38 kDa protein (TPA38), DnaK, GroEL, RplL
are currently under evaluation as next generation PPD
candidates [9,29,62,64-72]. PPD is a crude extract obtained
after several steps of filtration, purification, and precipita-
tion with trichloroacetic acid [30]. Enough knowledge on
PPD composition and contribution of individual antigens
in TST would give a better insight to understand the mo-
lecular mechanism behind it and will also allow the re-
searchers to select a combination of proteins specific to
M. tuberculosis. Our analysis further revealed mycobacter-
ial proteins in PPD-CT68 sharing identical amino acid se-
quence with lung infecting bacteria. Detailed epitopic
analysis of these proteins may help the researchers to
understand the mechanism behind cross reactivity in TST.
Mass Spectrometry is an efficient tool for proteomic
analysis due to its high mass accuracy, sensitivity and
ability to deal with complex sample mixtures. Here, in
this study we used a high resolution Fourier transform
mass spectrometer for LC-MS/MS analysis of PPD-
CT68. Many of the proteins identified in the PPD of
M. tuberculosis, have already been analyzed for their po-
tential as diagnostic markers. The complete protein pro-
file of PPD-CT68 uncovered from this study can be used
to analyze immune response and antibody production
pattern of body against different PPD antigens.
Data availability
The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org) via the PRIDE part-
ner repository [73] with the dataset identifier PXD000377.
Methods
Trypsin digestion
PPD-CT68 (100 μg protein) was subjected to in-solution
digestion using trypsin. Reduction and alkylation werecarried out using 5 mM dithiothreitol (60°C for 45 min)
and 20 mM iodoacetamide (RT for 10 min), respectively.
Overnight digestion was carried out using trypsin with an
enzyme: substrate ratio of 1:20 at 37°C [74]. The digest was
then purified using sep-pak C18 columns (WAT051910,
Waters Corporation, MA) [75] and the eluates were lyoph-
ilized at −52°C (Operon, Gyeonggi-do, Korea) and stored
at −80°C until LC−MS/MS analysis.
Mass spectrometry
We have carried out the LC-MS/MS analysis on an LTQ-
Orbitrap Velos ETD mass spectrometer (Thermo Scien-
tific, Bremen, Germany) interfaced with an Agilent 1100
HPLC system (Agilent Technologies, Santa Clara, CA).
Trypsin digested PPD peptides were analyzed on a re-
versed phase liquid chromatography. The RP-LC system
equipped with a pre-column (2 cm, 5 μ – 100A°), analyt-
ical column (10 cm, 5 μ – 100A°) made with magic AQ
C18 material (PM5/61100/00; Bruker-Michrom Inc.,
Auburn, CA) packed in-house. Further, the peptides were
sprayed using an electro-spray emitter tip 8 μ (New Ob-
jective, Woburn, MA) fixed to a nanospray ionization
source. The peptides were loaded on the pre-column using
97% solvent A (0.1% formic acid (aq) and resolved on the
analytical column using a gradient of 10-30% solvent B
(90% acetonitrile, 0.1% formic acid) for 60 min at a con-
stant flow rate of 0.35 μl/min. The spray voltage and
heated capillary temperature were set to 2.0 kV and 220°C,
respectively. The data acquisition was performed in a data
dependent manner. From each MS survey scan, 10 most
intense precursor ions were selected for fragmentation.
MS and MS/MS scans were acquired in an Orbitrap
mass analyzer and the peptides were fragmented by
higher energy collision dissociation with normalized
collision energy of 39%. MS scans were acquired at a
resolution of 60,000 at 400 m/z, while MS/MS scans
were acquired at a resolution of 15,000. The automatic
gain control for full FT MS was set to 0.5 million ions and
for FT MS/MS was set to 0.1 million ions with maximum
time of accumulation of 750 ms and 100 ms, respectively.
The raw data obtained was submitted to ProteomeXchange
Consortium (http://proteomecentral.proteomexchange.org).
Data analysis
We searched the MS/MS data using Sequest search algo-
rithm on Proteome Discoverer (version 1.3.0.339, Thermo
Scientific, Bremen, Germany), against protein database of
M. tuberculosis H37Rv strain downloaded from NCBI
RefSeq (updated December 29, 2011). The search parame-
ters are: a) precursor mass range between 350 to 8000 Da;
b) minimum peak count was set to 5; c) signal to noise
threshold set to 1.5; d) trypsin was used as a proteolytic
enzyme allowing up to one missed cleavage; e) precur-
sor mass tolerance of 20 ppm and fragment tolerance
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cation and carbamidomethylation of cysteine as fixed
modification; and g) 1% false discovery rate (FDR).
Additional files
Additional file 1: Table S1. List of peptides identified from M. tuberculosis
PPD (CT68).
Additional file 2: Table S2. List of proteins identified from M. tuberculosis
PPD (CT68).
Additional file 3: Table S3a. List of Mycobacterium tuberculosis
PPD-CT68 peptides with 10 or more amino acid identity with 24 lung
infecting bacteria. Table S3b. List of Mycobacterium tuberculosis
proteins corresponding to the peptides with 10 or more amino acid
identity with 24 lung infecting bacteria. Table S3c. List of
Mycobacterium tuberculosis proteins with sequence identity of ≥ 20
amino acid identity with 24 lung infecting bacteria.
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